Cancer specialists in the US potentially have access to hundreds of innovative trials and new treatments that could make all the difference to their patients. But identifying which trial is best suited to a specific patient is time-consuming; doing that work for multiple patients even more so. …
Author: David Prosser
* This article was originally published here
Matching Cancer Patients To Trials And Treatments With Triomics
Reviewed by Transaction Banker
on
May 09, 2024
Rating: